Trade BioMarin Pharmaceutical Inc - BMRN CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.26
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021596 %(-$4.32)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.02160%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000626 %(-$0.13)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.00063%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021596 %
  (-$4.32)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000626 %
  (-$0.13)

Key Stats

• Prev. Close: 66.93
• Open: 67.5
• 1-Year Change: 17.58%
• Day's Range: 67.5 - 69.02

Trade BioMarin Pharmaceutical Inc - BMRN

What is BioMarin (BMRN)?

BioMarin Pharmaceutical Inc. is a biotechnology company specializing in the development and commercialization of therapies for rare genetic diseases and serious medical conditions. The company focuses on innovative treatments that address unmet medical needs, often targeting small patient populations. BioMarin's product portfolio includes enzyme replacement therapies, gene therapies, and other biologics. It invests heavily in research and development to advance novel therapeutic approaches, including genetic medicine. The company collaborates with academic institutions, regulatory agencies, and other stakeholders to bring treatments to market. BioMarin operates globally, providing access to its therapies through various healthcare systems. Its mission centers on improving the quality of life for patients with rare disorders.

BioMarin Stock Price Today: Live Overview

The price today is shaped by the live market flow, with BioMarin priced at $68.79. The intraday fluctuation ranges from $67.43 to $69.26, accompanied by a daily change of +2.8085%.

FAQ: BioMarin (BMRN)

What is the current price of BMRN stock?

BioMarin's current price is $68.79.

Does BMRN pay dividends?

BioMarin pays dividends to its shareholders.

Does BMRN have a formal corporate presence or regional headquarters in the UAE?

BioMarin operates in the UAE through partners and distributors without an official regional office.

What is BMRN best known for?

BioMarin is most famous for developing therapies for rare genetic diseases.

What assets are typically shown together with BMRN?

Commonly shown alongside BMRN: BP Marsh & Partners PLC, McDonald's, Franklin Electric Co Inc